The Rt Hon. the Lord Cunningham of Felling DL is a member of the House of Lords since 2005. He is currently serving as a member of the Finance Committee and the Secondary Legislation Scrutiny Committee in the House of Lords. He served as the Chancellor of the Duchy of Lancaster and the Minister for the Cabinet Office during 1998-1999. Previously, he was the Secretary of State for Agriculture, Fisheries and Food from 1997-1998. During this time in the Ministry, he embarked on a modernisation programme. He also paved the way for the creation of the disputably independent Food Standards Agency. Lord Cunningham joined the Shadow Cabinet in 1983, and was appointed to be a Deputy Lieutenant of the County of Cumbria in 1991.
The Rt Hon. the Lord Jack Cunningham of Felling DL, House of Lords
”As a Global Ambassador of the G20 Health and Development Partnership, I would like to welcome and support the efforts of this initiative in raising the economic and social impact of some of the world’s deadliest diseases on the G20 heads of government, finance- and health ministers’ agenda.
Professor Abdullah Mohammed Aldahmash, Director General, Prince Naif Bin Abdulaziz Health Research Center at King Saud University
Professor Aldahmash is the Director General of the Prince Naif Bin Abdulaziz Health Research Center and Founder and Director of Stem Cell Unit at King Saud University. He is well-known for his great enthusiasm and passion for entrepreneurships and development in health care and academia. At his current position, professor Aldahmash has established a full ecosystem for medical research at King Saud Medical City. Previously, he was the Chairman of the Anatomy Department at the College of Medicine. Prior to this, he was the executive consultant for the president of King Saud University, Dr Abdullah Alothman during which he led different dedicated teams to establish innovative projects such as the Riyadh Tech Valley, King Abdullah institute for nanotechnology and stem cell unit. He was also appointed as the academic advisor at the Health Affairs Vice Rectorate of the Princess Noura University.
”As an initial supporter and now as a Global Ambassador of the G20 Health and Development Partnership, I fully support and welcome the recommendations set out to G20 leaders in various reports. I look forward to discussing them in Saudi Arabia in 2020, where NCDs account for 73% of deaths and constitute a major challenge to the national economy.
Elmar Brok, Member of the European Parliament (MEP), EDD Group, Germany
Elmar Brok has been member of the European Parliament since 1980. Currently, he serves as a member in the Committee on Foreign Affairs, Committee on Constitutional Affairs and the Delegation for relations with India. He served as the member of the Committee on Foreign Affairs and was the chair from 1999-2007 and 2012-2017. He is also a substitute member to the Committee on Employment and Social Affairs and to the Delegation to the United States, where he is a member since 1985 and was chair between 2009-2012. He is co-chair of the Transatlantic Legislators´ Dialogue (TLD) of the European Parliament and the US Congress since 1999 and is Co-Chairman of TPN. He is Deputy Chairman of the World Association of Christian Democrat International (CDI), President of the European Union of Christian Democratic Workers (EUCDW), Chairman of the CDU Federal Committee on European Policy and Chairman of the board of the European Endowment for Democracy (EED). He is also Member of the CDU Federal Board; Member of the Executive National Council of the CDU NRW and Member of the party executive of the EPP and Co-Chairman of the EPP-foreign minister. Previously, he was EPP representative at the European Parliament Intergovernmental Conferences on the Treaty of Lisbon, EU Constitutional Treaty (2003/2004), Treaty of Nice (2000), Treaty of Amsterdam (1996/97) and on the Council’s Reflection Group preparing the Maastricht Treaty. In 1990, he was Chairman of the EPP in the Special Committee on German Unification. Between 1973-1983, he was Deputy Chairman of the Junge Union, Vice Chairman and Chairman of the Democrat Youth Committee of Europe from 1977 to 1981, Vice Chairman of the International Democrat Union from 1991 to 2003 and Founding Chairman of the International Democrat Youth Union.
”As a Global Ambassador of the G20 Health and Development Partnership, I call upon the G20 leaders, health and finance ministers to incentivize innovative financing models for advancing global health innovation to ensure better health for all.
Paul Ruebig, Member of the European Parliament since 1996 and belongs to the European People’s Party (EPP)
Dr. Paul Ruebig, born in Wels (Upper Austria), has been member of the European Parliament since 1996 and belongs to the European People’s Party (EPP). He is married and has two children.
Paul Ruebig is full member of the Committee on Industry, Research and Energy and the Committee on Budgets. In addition, he is substitute member of the Committee on Development and in the Committee on International Trade. Furthermore Paul Rübig is member and Vice-Chair of the Delegation for Relations with the Korean Peninsula and substitute member of the Delegation for relations with Switzerland, Norway and the EU-Iceland and the European Economic Area Joint Parliamentary Committee.
Paul Ruebig is very active in the field of the small-scale business promotion. He is president of SME Global, a working group of the International Democrat Union (IDU), whose objective it is to support small and medium-sized enterprises (SME) and to improve their business environment. Since 2014, he has been the Chairman of STOA (Scientific Technology Options Assessment), an official body of the European Parliament that is supported by external experts such as universities, scientists or research institutes.
Furthermore, he is Co-Chairman of the WTO Steering Committee in the European Parliament, as well as of the WTO Parliamentary Assembly.
”My goal as a European lawmaker is to support the connection of the different sectors when it comes to health: Research, innovation, budget and social security systems. With the Science Media Hub, just to mention one example, we implemented a helpful tool for the connection of knowledge within the fields of experts in science. I appreciate this very important Health Initiative within the G20 Partnership - cooperation is the only way to solve global issues and to shape the future of better living together.
Philippe Fauchet, OBE, Founder of Mirasense Partners, Consulting Services for Life Sciences and Senior Advisor to the European Federation of Pharmaceutical Industries and Associations (EFPIA), Japan
Philippe Fauchet, OBE is the founder of Mirasense Partners, Consulting Services for Life Sciences. He was the Vice Chairman of the European Federation of Pharmaceutical Industries and Associations (EFPIA) Japan until June 2018. He is now Senior Advisor to EFPIA. He has been regularly elected to the board of the British Chamber of Commerce in Japan (BCCJ) since April 2015 and until March 2019. Philippe is also appointed French Foreign Trade Advisor (CCE). Philippe Fauchet joined GlaxoSmithKline K.K. as President & Representative Director in January 2010. In April 2018, he was appointed Chairman, GlaxoSmithKline K.K. Philippe joined the company from Sanofi-Aventis where he was Senior Vice President, Corporate Business Development Head of Sanofi-Aventis Group. He had been a member of the Management Committee of Sanofi-Aventis Group from 2005. Philippe started his career in the pharmaceutical industry in 1984 at Roussel Uclaf, then Hoechst Marion Roussel where he occupied, among others, various positions related to the Asia Pacific including positions based in Japan and Korea from 1989 to 1994, as well as positions in marketing and research & development. He joined Sanofi-Synthelabo in 1996 and held regional positions including Vice President for Eastern & Central Europe, before serving in Japan as President & Representative Director of Sanofi-Synthelabo K.K. from 2001-2004, then of Sanofi-Aventis K.K. until 2008. Philippe has spent 35 years in the pharmaceutical industry, of which 20 in Japan. He is also an advisor to Suzuken Group, M3, and a few Biotechs/Start-up companies, and director on the Board of BONAC Corporation. He was awarded Honorary Officer of the Most Excellent Order of the British Empire (OBE) in October 2014.
”I feel the need in uncertain times to unite behind legitimate causes that can make the world better and provide a positive legacy for the next generations. Health for all is still not achieved, in developed and less developed countries, despite all efforts and emphasis put behind the United Nations SDG3. Moreover, there is a need to better coordinate all stakeholders action in the fight against NCDs, tropical diseases, AMR and pandemic preparedness. The development of new technologies offers opportunities to develop innovative solutions to tackle some of the global health issues. Moreover, political convergence to support this agenda, as initiated during the Berlin G20 Summit and pursued on the occasion of the Osaka Summit, offers a unique chance to obtain alignment of Health and Finance Ministers on supportive policies for ‘healthy finance mechanisms’ that would help channeling investment towards above agenda, and I am pleased to assist the G20 Health and Development Partnership for a positive outcome in Japan.